Point Lookout Capital Partners

Point Lookout Capital Partners is a New York-based private equity firm that specializes in providing equity capital to middle-market companies, with a particular focus on the healthcare and life sciences sectors. The firm invests in a variety of sub-sectors, including biotechnology, medical devices, and healthcare services, often targeting companies with revenues between $10 million and $100 million. Point Lookout typically provides growth capital or facilitates buyouts, partnering with management teams to enhance operational value. Their historical portfolio includes investments in contract research organizations like Toxikon and drug development companies such as VaxInnate and Metabolic Solutions Development Company. The firm seeks to identify businesses with proprietary technologies or unique market positions that are poised for significant expansion.